Healthcare Professionals – e-Learning

Learning Objectives:

At the end of this on-demand webinar, you will be able to:

• Recall updates to NACI recommendations for influenza vaccination and expected changes to vaccine composition.
• Describe the role of real-world evidence in evaluating the effectiveness of influenza vaccination in specific populations.
• Explain the association between influenza infection and cardiovascular events, loss of functional independence, and frailty in older adults.
• Describe implementation strategies to support older adult patients in the pharmacy during the busy influenza season.

Supported by educational funding from CSL Seqirus.

Visit eCortex.ca to register.

Learning Objectives:

At the end of this on-demand webinar, you will be able to:

• Understand the burden of influenza and its consequences on the older adult population (65+ years)
• Discuss recommendations for seasonal influenza under the NACI statement for the 2024-2025 season
• Describe different influenza vaccine recommendations based on evidence-based recommendations
• Discuss best practices for influenza vaccination delivery based on age group and health outcomes using clinical/case studies

This program is an unaccredited learning activity supported by educational funding from Sanofi.

Visit eCortex.ca to register.

This training module is intended as a refresher on how to administer the flu vaccine. The module can be completed within 30 minutes.

The iMD Patient Engagement Platform is a web-based patient education platform that is available on any device with internet. iMD Health enables healthcare providers to bring their patient sessions to life through the seamless integration of professionally-vetted diagrams, educational resources, brochures and videos covering over 1,800 medical conditions, procedures and treatment options.

To get your account, visit app.imdhealth.com/signup.

Discover how simple 30-second conversations can protect patients while strengthening your professional relationships. Get up to date on the latest NACI recommendations and vaccine data in a format that respects your time. Transform routine interactions into life-saving opportunities with this game-changing approach to pharmacy-based vaccination.

Learning Objectives

After completion of the webinar participants will be better able to:

• Implement the AIMS approach and presumptive offer technique to increase patient vaccine acceptance during routine pharmacy interactions.
• Identify and proactively engage high-risk patients requiring vaccination and integrate screening into existing workflows without disrupting operations.
• Apply current NACI recommendations for COVID-19 and influenza vaccination, including safe co-administration protocols, to ensure optimal patient protection.
• Evaluate patient vaccine concerns and demonstrate evidence-based and empathetic communication strategies.
• Determine the steps to coordinate the entire pharmacy team to maximize vaccination opportunities and improve community health outcomes among vulnerable populations.

If you are a Pharmacist, visit RxBriefCase to register.

RSV strikes early, but you can strike first. No Infant Left Unprotected: Action-Ready Strategies for RSV Season 2025-26 is a concise, case-based lesson that distills NACI’s universal-immunization guidance, the season-long RSV protection and proven presumptive-offer scripts that boost caregiver acceptance into an actionable playbook. In under an hour, you’ll learn how to rapidly identify and recall every at-risk infant and leave with ready-to-use strategies that ensure that no baby in your practice faces RSV unprotected.

Learning objectives:
After viewing this microlearning, participants will be better able to:

• Describe the significant burden of RSV in all Canadian infants and identify infants recommended for RSV prophylaxis according to the latest NACI recommendations
• Interpret the efficacy and real-world evidence for nirsevimab in preventing severe RSV-related outcomes
• Apply a presumptive communication model to confidently recommend RSV immunization and effectively address caregiver questions
• Develop practical, clinic-level processes for identifying, recalling, and immunizing eligible infants, including the “catch-up” cohort for RSV protection

If you are a Physician/Nurse/Specialist, please visit MDBriefCase to register.

If you are a Pharmacist, visit RxBriefCase to register.

Respiratory syncytial virus (RSV) is the leading cause of hospitalization in infants under 12 months, yet many infants born outside of the RSV season are unintentionally missed by hospital-based prevention programs. In this short video, experts will share practical, evidence-based strategies for identifying at-risk infants, communicating effectively with caregivers, and implementing catch-up protection using long-acting monoclonal antibody therapy.

Learning objectives:
After viewing this expert brief, participants will be better able to:

• Describe the burden and seasonality of RSV in infants and the rationale for universal prevention strategies
• Identify infants born outside of the RSV season who may not have been immunized against RSV
• Apply communication strategies and clinic-based workflows to support RSV catch-up immunization in primary care

If you are a Physician/Nurse/Specialist, please visit MDBriefCase to register.

If you are a Pharmacist, visit RxBriefCase to register.

Respiratory syncytial virus (RSV) remains the leading cause of hospitalization in Canadian infants. While hospital-based administration of nirsevimab may be addressing in-season births in many regions in Canada, many infants born between April and November and those previous not immunized remain at risk unless proactively identified and immunized by primary care. In this short 5-minute microlearning session, Dr. Jane Healey outlines practical, evidence-based strategies to close the RSV protection gap and ensure that no infant enters RSV season unprotected.

Learning objectives:
After viewing this microlearning, participants will be better able to:

• Recognize the clinical urgency of identifying and protecting unimmunized infants against RSV, with a focus on those born April–November.
• Apply recommended strategies for implementing and communicating catch-up RSV immunization protocols in primary care.

If you are a Physician/Nurse/Specialist, please visit MDBriefCase to register.

If you are a Pharmacist, visit RxBriefCase to register.

Protecting with Confidence: A Parent’s Guide to RSV Protection for Infants is a short, evidence-based educational animation designed to help parents understand the benefits of RSV immunization for infants. Through a warm, relatable conversation between a healthcare provider and new parents, the program addresses common questions, explains the risk of severe RSV disease, and reinforces the safety and effectiveness of nirsevimab (Beyfortus®) as a single-dose protective antibody.

Learning objectives:
By the end of this program, participants will be able to:

• Describe the burden and potential severity of RSV infection in infants during their first season
• Explain how nirsevimab provides season-long RSV protection and address common parental concerns about co-administration with routine vaccines

If you are a Physician/Nurse/Specialist, please visit MDBriefCase to register.

If you are a Pharmacist, visit RxBriefCase to register.

This 60-minute webinar will focus on the epidemiology, burden, and prevention of IMD, particularly in high-risk populations such as travellers, individuals attending mass gatherings, and older adults at risk. The session will highlight the importance of quadrivalent meningococcal conjugate vaccines and their role in preventing IMD in pre-travel consultations and geriatric consultations.

Learning objectives:
After completion of the webinar participants will be better able to:

• Describe the epidemiology and burden of invasive meningococcal disease (IMD)
• Differentiate quadrivalent conjugate meningococcal vaccines
• Evaluate clinical, safety, and administration data for the latest IMD vaccine (MenACWY-TT), including its immune response benefits and simplified administration
• Implement appropriate vaccination strategies for travellers and older adults at risk based on the latest evidence and guidelines

If you are a Physician/Nurse/Specialist, please visit MDBriefCase to register.

If you are a Pharmacist, visit RxBriefCase to register.

Target Audience and Goal Statement

This educational activity is intended for an audience of primary care physicians, infectious disease specialists, and public health and preventative medicine specialists.

The goal of this activity is for learners to be better able to identify individuals at risk and how to communicate with potential recipients about the risk/benefit of chikungunya virus vaccines.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
  • Latest data on the burden of chikungunya disease
  • Data on chikungunya virus vaccines
• Have greater competence related to
  • Identifying who would benefit from the chikungunya vaccine

Visit Medscape to register.

Target Audience and Goal Statement

This educational activity is intended for a global audience of primary care physicians, infectious disease specialists, public health and preventative medicine specialists, nurses, and pharmacists.

The goal of this activity is for learners to be better able to identify patients who are at risk for JEV infection, and be aware of the different Japanese encephalitis vaccines.

Upon completion of this activity, participants will:

• Have increased knowledge regarding the
  • Characteristics of JEV acquisition (eg, by < 1 month duration)
  • JEV vaccines
• Have greater competence in
  • Identifying travelers who are at risk of JEV

Visit Medscape to register.

Learning Objectives:

• Describe the impact of climate change on the risk of insect-borne diseases during travel.
• Explain the epidemiology, clinical presentation, outcomes and risks of common mosquito-borne diseases.
• Determine the non-pharmacological recommendations for the protection against mosquito-borne diseases.
• Discuss the different vaccine options to protect against different mosquito-borne diseases related to travel.

Supported by educational funding from Valneva.

Visit eCortex.ca to register.

A rising number of Canadians are diagnosed with Lyme disease each year. This program aims to help clinicians effectively identify and treat Lyme disease in their patients. The program will review the clinical presentation and treatment of Lyme disease, with the overall goal of supporting clinicians in optimizingearly recognition and treatment of this condition.

Learning objectives:

Upon completion of this continuing education program, participants will be better able to:

• Describe the clinical presentation of Lyme disease
• Discuss appropriate treatment options for Lyme disease
• Advise patients on preventative measures for Lyme disease

If you are a Pharmacist, visit RxBriefCase to register.

Respiratory Syncytial Virus (RSV) represents a significant health threat to older adults, leading to severe respiratory complications and heightened mortality rates. This focused webinar explores the significant impact of RSV in older adults, the latest advancements in RSV vaccination, and practical strategies for integrating vaccination into clinical practice. This session will guide clinicians through understanding the current burden of RSV, comparing safety and efficacy data between available vaccines, and implementing the National Advisory Committee on Immunization’s (NACI) recommendations to optimize patient outcomes. Whether you’re looking to deepen your knowledge or refine your approach to patient care, this webinar will provide valuable insights and actionable strategies.

This program has received an unrestricted educational grant or in-kind support from Moderna Biopharm Canada Inc.

Learning objectives:

Upon completion of this webinar, participants will be better able to:

• Discuss the current NACI recommendations for RSV vaccination in older adults
• Compare the safety and efficacy data between available RSV vaccines for older adults
• Describe strategies to integrate RSV vaccination into clinical practice

Visit mdBriefCase to register.

Discover how simple 30-second conversations can protect patients while strengthening your professional relationships. Get up to date on the latest NACI recommendations and vaccine data in a format that respects your time. Transform routine interactions into life-saving opportunities with this game-changing approach to pharmacy-based vaccination.

Learning Objectives

After completion of the webinar participants will be better able to:

• Implement the AIMS approach and presumptive offer technique to increase patient vaccine acceptance during routine pharmacy interactions.
• Identify and proactively engage high-risk patients requiring vaccination and integrate screening into existing workflows without disrupting operations.
• Apply current NACI recommendations for COVID-19 and influenza vaccination, including safe co-administration protocols, to ensure optimal patient protection.
• Evaluate patient vaccine concerns and demonstrate evidence-based and empathetic communication strategies.
• Determine the steps to coordinate the entire pharmacy team to maximize vaccination opportunities and improve community health outcomes among vulnerable populations.

If you are a Pharmacist, visit RxBriefCase to register.